Api Details

Levetiracetam is a crucial pharmaceutical API used in the treatment of epilepsy and seizures. It belongs to the class of antiepileptic drugs, which work by modulating neurotransmitter activity in the brain to prevent abnormal electrical activity that can lead to seizures. Levetiracetam is particularly effective as an adjunctive therapy in patients with partial-onset seizures, generalized tonic-clonic seizures, and myoclonic seizures. Administered orally, dosages vary based on the specific seizure type and individual patient factors. While generally well-tolerated, potential side effects may include dizziness, drowsiness, and behavioral changes. Regulatory adherence ensures stringent quality and safety standards during manufacturing, ensuring reliability in Levetiracetam-containing pharmaceutical products.